Low hematocrit and hemoglobin and jp drain

Anemia due to myelosuppressive chemotherapy - for treatment in members with nonmyeloid malignancy and pretreatment hemoglobin is less than 10 g/dL or.Anemia due to chronic kidney disease (CKD) - for treatment in members with pretreatment hemoglobin less than 10 g/dL or.Epoetin alfa (Epogen, Procrit) and epoetin alfa-epbxВ (Retacrit)ДЄetna considers erythropoietin therapy epoetin alfa (Epogen/Procrit) andВ epoetin alpha-epbx (Retacrit) medically necessary for any of the following indications when criteria are met:

Members may not useВ these agentsВ concomitantly with other erythropoiesis stimulating agents. All members must be assessed for iron deficiency anemia and have adequate iron stores (defined as a serum transferrin saturation level greater than or equal to 20% within the prior 3 months) or are receiving iron therapy before starting erythropoiesis stimulating agents (Epogen, Procrit, Retacrit, Aranesp and Mircera). Note: Requirements regarding pretreatment hemoglobin level exclude values due to a recent transfusion. Precertification of erythropoiesis stimulating agents (Aranesp, Epogen, Procrit, Retacrit, Mircera) is required of all Aetna participating providers and members in applicable plan designs. Therefore, Aetna considers Epogen, Procrit, and Mircera to be medically necessary only for members who have a contraindication, intolerance or ineffective response to the available equivalent alternatives Retacrit and Aranesp. There is a lack of reliable evidence that Epogen, Procrit, and Mircera are superior to the lower cost epoetin products: Retacrit and Aranesp for medically necessary indications. Epogen, Procrit, and Mircera epoetin products are more costly to Aetna than other epoetin products. Commercial CPB | Medicare CPB Brand Selection for Medically Necessary IndicationsДЄs defined in Aetna commercial policies, health care services are not medically necessary when they are more costly than alternative services that are at least as likely to produce equivalent therapeutic or diagnostic results.

Low hematocrit and hemoglobin and jp drain